Indegene Limited Share Price & Analysis
₹507.75▼ -0.27%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹507.75
-0.27%
Open
₹—
High
₹512
Low
₹505
Close
₹507.75
52W High
₹597
52W Low
₹414
Volume
54K
Lot Size
1
Sector
Healthcare
Market Cap
₹12K Cr
Face Value
₹2
Mid CapNIFTY 500
Price Chart
Fundamentals
P/E
29.7
Sector P/E
54.4
P/B
3.97
EPS
₹16.62
ROE
14.4%
ROCE
18.8%
D/E Ratio
0.05
Div Yield
0.44%
Book Value
₹130
+
Strengths
- ✓Efficient capital deployment (ROCE 18.8%)
- ✓Attractively valued vs sector (P/E 29.7x vs industry 54.4x)
- ✓Virtually debt-free
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Corporate Events
To consider and approve the financial results for the period ended Jun 30, 2026
Results29 Jul 2026
Dividend - Rs 2 Per Share
Dividend12 Jun 2025
Annual General Meeting
AGM28 Aug 2024
Latest News
All news →Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.0K Cr ▲6.5% | ₹942 Cr ▲17.2% | ₹804 Cr ▲5.7% | ₹761 Cr ▲0.7% | ₹756 Cr ▲5.0% | ₹720 Cr ▲4.8% | ₹687 Cr ▲1.6% | ₹676 Cr |
| Op. Profit | ₹164 Cr ▲2.5% | ₹160 Cr ▲13.5% | ₹141 Cr ▼9.0% | ₹155 Cr ▲4.7% | ₹148 Cr ▲12.1% | ₹132 Cr ▲4.8% | ₹126 Cr ▼2.3% | ₹129 Cr |
| OPM | 16.0% ▼5.9% | 17.0% ▲0.0% | 17.0% ▼15.0% | 20.0% ▲0.0% | 20.0% ▲11.1% | 18.0% ▲0.0% | 18.0% ▼5.3% | 19.0% |
| Net Profit | ₹80 Cr ▼22.3% | ₹103 Cr ▲1.0% | ₹102 Cr ▼12.1% | ₹116 Cr ▼1.7% | ₹118 Cr ▲7.3% | ₹110 Cr ▲19.6% | ₹92 Cr ▲4.5% | ₹88 Cr |
| EPS (₹) | 3.31 ▼22.7% | 4.28 ▲0.7% | 4.25 ▼12.4% | 4.85 ▼1.0% | 4.9 ▲7.0% | 4.58 ▲19.6% | 3.83 ▲4.4% | 3.67 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹3.5K Cr ▲23.6% | ₹2.8K Cr ▲9.6% | ₹2.6K Cr ▲12.3% | ₹2.3K Cr ▲38.5% | ₹1.7K Cr ▲72.4% | ₹966 Cr ▲50.2% | ₹643 Cr ▲16.3% | ₹553 Cr |
| Expenses | ₹2.9K Cr ▲26.2% | ₹2.3K Cr ▲10.0% | ₹2.1K Cr ▲9.1% | ₹1.9K Cr ▲38.6% | ₹1.4K Cr ▲87.2% | ₹736 Cr ▲47.5% | ₹499 Cr ▼2.3% | ₹511 Cr |
| Op. Profit | ₹619 Cr ▲13.0% | ₹548 Cr ▲8.5% | ₹505 Cr ▲27.5% | ₹396 Cr ▲38.0% | ₹287 Cr ▲24.8% | ₹230 Cr ▲59.7% | ₹144 Cr ▲242.9% | ₹42 Cr |
| OPM | 18.0% ▼5.3% | 19.0% ▼5.0% | 20.0% ▲17.6% | 17.0% ▲0.0% | 17.0% ▼29.2% | 24.0% ▲9.1% | 22.0% ▲175.0% | 8.0% |
| Other Income | ₹52 Cr ▼44.7% | ₹94 Cr ▲19.0% | ₹79 Cr ▲36.2% | ₹58 Cr ▲376.2% | ₹-21 Cr ▼600.0% | ₹-3 Cr ▲97.1% | ₹-102 Cr ▼1557.1% | ₹7 Cr |
| Interest | ₹19 Cr ▼13.6% | ₹22 Cr ▼55.1% | ₹49 Cr ▲58.1% | ₹31 Cr ▲416.7% | ₹6 Cr ▼14.3% | ₹7 Cr ▼22.2% | ₹9 Cr ▲50.0% | ₹6 Cr |
| Depreciation | ₹126 Cr ▲57.5% | ₹80 Cr ▲5.3% | ₹76 Cr ▲26.7% | ₹60 Cr ▲81.8% | ₹33 Cr ▲26.9% | ₹26 Cr ▲36.8% | ₹19 Cr ▲11.8% | ₹17 Cr |
| PBT | ₹525 Cr ▼2.6% | ₹539 Cr ▲17.4% | ₹459 Cr ▲26.4% | ₹363 Cr ▲60.6% | ₹226 Cr ▲15.9% | ₹195 Cr ▲1292.9% | ₹14 Cr ▼46.2% | ₹26 Cr |
| Tax % | 24.0% ▼4.0% | 25.0% ▼7.4% | 27.0% ▲0.0% | 27.0% ▼3.6% | 28.0% ▲21.7% | 23.0% ▼88.0% | 191.0% ▲324.4% | 45.0% |
| Net Profit | ₹401 Cr ▼1.5% | ₹407 Cr ▲20.8% | ₹337 Cr ▲26.7% | ₹266 Cr ▲63.2% | ₹163 Cr ▲9.4% | ₹149 Cr ▲1341.7% | ₹-12 Cr ▼185.7% | ₹14 Cr |
| EPS (₹) | 16.65 ▼1.8% | 16.95 ▲12.0% | 15.14 ▲26.3% | 11.99 ▼98.7% | 937.73 ▼1.5% | 951.96 ▲2468.1% | -40.2 ▼144.7% | 89.98 |
| Div Payout | 13.0% ▲8.3% | 12.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||
| Equity Capital | ₹48 Cr ▲0.0% | ₹48 Cr ▲9.1% | ₹44 Cr ▲0.0% | ₹44 Cr ▲12471.4% | ₹0.35 Cr ▲12.9% | ₹0.31 Cr ▲0.0% | ₹0.31 Cr ▲0.0% | ₹0.31 Cr |
| Reserves | ₹3.1K Cr ▲20.4% | ₹2.6K Cr ▲85.4% | ₹1.4K Cr ▲35.8% | ₹1.0K Cr ▲33.5% | ₹764 Cr ▲135.8% | ₹324 Cr ▲408.6% | ₹-105 Cr ▼243.8% | ₹73 Cr |
| Borrowings | ₹144 Cr ▲41.2% | ₹102 Cr ▼79.2% | ₹490 Cr ▼2.4% | ₹502 Cr ▲660.6% | ₹66 Cr ▲29.4% | ₹51 Cr ▼89.4% | ₹483 Cr ▲228.6% | ₹147 Cr |
| Other Liabilities | ₹1.3K Cr ▲119.5% | ₹609 Cr ▼2.9% | ₹627 Cr ▼1.7% | ₹638 Cr ▲21.8% | ₹524 Cr ▲138.2% | ₹220 Cr ▼0.9% | ₹222 Cr ▲105.6% | ₹108 Cr |
| Total Liabilities | ₹4.6K Cr ▲38.9% | ₹3.3K Cr ▲30.6% | ₹2.5K Cr ▲15.5% | ₹2.2K Cr ▲62.9% | ₹1.4K Cr ▲127.0% | ₹596 Cr ▼0.7% | ₹600 Cr ▲82.4% | ₹329 Cr |
| Assets | ||||||||
| Fixed Assets | ₹1.8K Cr ▲167.3% | ₹678 Cr ▲5.0% | ₹646 Cr ▼2.7% | ₹664 Cr ▲381.2% | ₹138 Cr ▲60.5% | ₹86 Cr ▼27.7% | ₹119 Cr ▲14.4% | ₹104 Cr |
| CWIP | ₹12 Cr ▲200.0% | ₹4 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹1.1K Cr ▼14.7% | ₹1.3K Cr ▲62.1% | ₹796 Cr ▲29.6% | ₹614 Cr ▲411.7% | ₹120 Cr | ₹0 Cr ▼100.0% | ₹13 Cr | ₹0 Cr |
| Other Assets | ₹1.7K Cr ▲25.2% | ₹1.4K Cr ▲22.8% | ₹1.1K Cr ▲19.1% | ₹926 Cr ▼15.5% | ₹1.1K Cr ▲114.9% | ₹510 Cr ▲9.0% | ₹468 Cr ▲108.0% | ₹225 Cr |
| Total Assets | ₹4.6K Cr ▲38.9% | ₹3.3K Cr ▲30.6% | ₹2.5K Cr ▲15.5% | ₹2.2K Cr ▲62.9% | ₹1.4K Cr ▲127.0% | ₹596 Cr ▼0.7% | ₹600 Cr ▲82.4% | ₹329 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹651 Cr ▲47.3% | ₹442 Cr ▼13.0% | ₹508 Cr ▲290.8% | ₹130 Cr ▼56.2% | ₹297 Cr ▲72.7% | ₹172 Cr ▲681.8% | ₹22 Cr ▼66.2% | ₹65 Cr |
| Investing CF | ₹-512 Cr ▲24.4% | ₹-677 Cr ▼107.7% | ₹-326 Cr ▲63.6% | ₹-896 Cr ▼467.1% | ₹-158 Cr ▼95.1% | ₹-81 Cr ▼406.3% | ₹-16 Cr ▲11.1% | ₹-18 Cr |
| Financing CF | ₹-83 Cr ▼128.8% | ₹288 Cr ▲536.4% | ₹-66 Cr ▼119.8% | ₹333 Cr ▲42.9% | ₹233 Cr ▲276.5% | ₹-132 Cr ▼197.1% | ₹136 Cr ▲747.6% | ₹-21 Cr |
| Net Cash Flow | ₹56 Cr ▲7.7% | ₹52 Cr ▼54.8% | ₹115 Cr ▲126.6% | ₹-433 Cr ▼216.1% | ₹373 Cr ▲1032.5% | ₹-40 Cr ▼128.0% | ₹143 Cr ▲472.0% | ₹25 Cr |
| Free Cash Flow | ₹606 Cr ▲47.1% | ₹412 Cr ▼17.1% | ₹497 Cr ▲347.7% | ₹111 Cr ▼59.2% | ₹272 Cr ▲80.1% | ₹151 Cr ▲843.8% | ₹16 Cr ▼66.7% | ₹48 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 80d ▼17.5% | 97d ▲6.6% | 91d ▼10.8% | 102d ▲5.2% | 97d ▼10.2% | 108d ▼15.0% | 127d ▲111.7% | 60d |
| Inventory Days | — | — | — | — | — | — | — | — |
| Days Payable | — | — | — | — | — | — | — | — |
| Cash Conv. Cycle | 80d ▼17.5% | 97d ▲6.6% | 91d ▼10.8% | 102d ▲5.2% | 97d ▼10.2% | 108d ▼15.0% | 127d ▲111.7% | 60d |
| Working Capital Days | 120d ▲207.7% | 39d ▲44.4% | 27d ▼34.1% | 41d ▲272.7% | 11d ▼75.6% | 45d ▲1000.0% | -5d ▲28.6% | -7d |
| ROCE | 19.0% ▼24.0% | 25.0% ▼13.8% | 29.0% ▼12.1% | 33.0% ▼28.3% | 46.0% ▼16.4% | 55.0% ▲48.6% | 37.0% | — |
Source: Screener.in · Lower days = better efficiency
About Indegene Limited
Incorporated in 1998, Indegene Ltd provides solutions consisting of analytics, technology and commercial, medical, regulatory and safety services to life science and health care organizations[1]
Healthcare · Healthcare Services
Related Analysis
Frequently Asked Questions
What is Indegene Limited share price today?▾
Indegene Limited (INDGN) is currently trading at ₹507.75 on NSE, down 0.27% as of the last market session. Prices update daily after market close on MarketNetra.
Is Indegene Limited available in F&O (Futures & Options)?▾
Yes, Indegene Limited (INDGN) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Indegene Limited 52-week high and low?▾
Indegene Limited's 52-week high is ₹597 and the 52-week low is ₹414. The current price of ₹507.75 is 14.9% below the 52W high.
What is Indegene Limited P/E ratio?▾
Indegene Limited's current P/E ratio is 29.7. This indicates the market is paying ₹29.7 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Indegene Limited options?▾
Indegene Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade INDGN options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.